patients into normal sweat glands in situ induces a defect in Na'
effectors. No differences were observed between cells pretreated with serum and cells to which serum was added at the time of cholinergic stimulation of secretion. At high concentrations, serum from both normal individuals and those with cystic fibrosis severely damaged the cells in a rapid and irreversible fashion. K+ transport has a direct, closely coupled, specific relationship to secretory activity and is Ca" dependent in this system. From these observations, we conclude that serum from individuals with cystic fibrosis does not contain chemical compounds which specifically alter the major components of ion-coupling to secretion or the secretory process itself in salivary gland acinar cells.
Speculation
If a cystic fibrosis factor affecting ion-coupled exocrine secretion exists in serum, it is present at concentrations too low to be detected or acts upon a cell type other than the acinar cell.
The electrolyte abnormality in eccrine sweat of cystic fibrosis (CF) patients, was first described by di Sant'Agnese et al. (8) in 1953. This quantitative increase in sweat electrolytes is the phenotypic change most consistently demonstrable in the CF patient. Because this finding is independent of the age or the clinical status of the patient (I, 10, 29) , the electrolyte abnormality appears to be a primary manifestation of the basic molecular defect underlying CF. There is no major morphologic alteration of the sweat gland (19). The elevated concentrations of sweat electrolytes reflect a disturbance in cation transport which is generalized among exocrine glands and restricted to them. Increased concentrations of electrolytes are a regular feature of mixed salivary gland and parotid saliva (4, 9, 14) , and quantitative abnormalities in ion composition of other exocrine secretions also occur (7) .
Several observations suggest that the electrolyte abnormality is mediated by a humoral component. Retrograde perfusion of sweat from patients with CF into the ducts of rat parotid glands inhibits Na' reabsorption from the primary secretory product of the parotid glands (16, 17). Intraluminal injection of sweat from CF ieabsorption upon subsequLnt stimulation of sweat secretion with pilocarpine (13) . I n vitro microperfusion of CF sweat exerts a similar effect upon the normal sweat gland (15) . Mixed saliva and saliva from the sublingual, submandibular, and submucosal glands of patients with CF inhibit cation reabsorption in the rat parotid gland bioassay (32) but have no specific effect on erythrocyte cation transport (12) . Although serum from patients with CF also has been reported to contain bioactive "factors" which are not present, or present in lower concentrations, in serum from normal individuals (2, 5, 6, 31, 33) , no quantitative assessment of their activity upon exocrine cells has been reported.
The cardinal nature of the exocrine gland dysfunction in CF, the humoral nature of the inhibitors of sweat and salivary gland cation transport, and the existence of bioactive serum factors led us to investigate the specific capacity of CF serum to modulate cation transport in cells of the rat submandibular gland, a seromucous exocrine gland. In this gland and other exocrine glands, a-adrenergic and muscarinic cholinergic agonists as well as certain polypeptides are known to stimulate secretory activity (IS, 20, 21, 25, 26 ). An early event associated with this stimulation is the marked and rapid change in membrane permeability to K+ (18, 20, 23, 26, 27, 30) , and the release of intracellular K' by these secretagogues is dependent upon extracellular Ca" (21, 22, 24, 27, 30) . The dispersed submandibular gland preparation thus allows, in a single bioassay, the search for C F factor(s) which modify acinar cell receptor response to secretagogues, which alter the distinct ion channels involved in cation efflux and re-entry, or which effect changes in Ca" homeostastis in these cells. A significant alteration of any of these components of the secretory process by CF factor@) is expected to lead to a demonstrable change in K' transport. This bioassay also was chosen for the following additional reasons: (1) it is an appropriate model system because it is a mammalian exocrine gland, one which is pathophysiologically altered in CF; (2) retrograde perfusion experiments have suggested that a closely related gland from the rat, the parotid, is responsive to CF humoral factor(s); (3) dispersed cell suspension of this organ has been perfected, obviating many technical problems associated with in vivo perfusion and in vitro gland slice experiments (21-23); (4) a pharmacologic description of the ion-coupled secretory response is available (23) (24) (25) ; (5) responses of the bioassay are readily quantitated, a necessary attribute for the rigorous demonstration and characterization of a bioactive factor.
METHODS
Blood was obtained from three female and four male patients with CF, ages 8 to 22 years, who had clinical, radiologic, and sweat electrolyte findings classical for this disease. All were out-patients of the Cystic Fibrosis Center of Oklahoma Children's Memorial Hospital and were receiving pancreatic supplements (Pancrease; Johnson & Johnson, New Brunswick, NJ). Two patients were receiving carbenicillin, three were receiving oxytetracycline, and two were not being treated with antibiotics. Normal subjects serving as age (10 to 23 years) and sex-matched controls were healthy individuals taking no medications and who had no personal or family history of CF. Informed consent of all subjects was obtained according to Department of Health, Education, and Welfare guidelines.
PREPARATION OF DISPERSED CELL SUSPENSION
Rat submandibular gland cells were obtained by enzymatic dispersion using chromatographically purified collagenase and hyaluronidase according to the method recently developed by Quissell and Redman (25) . Male Sprague-Dawley rats (approximately 200 g) obtained from Charles River Breeding Laboratory were anesthetized by intraperitoneal injection of sodium pentobarbital (6 to 10 mg/100 g body weight), and after severing the abdominal aorta to effect exsanguination, the submandibular glands were removed. The submandibular glands were dissected from the sublingual glands, quickly minced in a dispersion solution of Ca-, Mg-, free Hanks' salt solution containing 15 mM 4-(2-hydroxyethy1)-piperazineethanesulfonic acid buffer, pH 7.4, with 75 U/ml chromatographically purified collagenase (Worthington Biochemical Corp., Freehald, NJ) and 1.0 mg/ml hyaluronidase (Sigma Chemical Co., St. Louis, MO). The suspension was incubated in a gyrotory shaker for 60 rnin at 37' in an atmosphere of 95% 02-5% COa. After incubation, the cells were washed twice in the suspending buffer without enzymes and passed through a nylon mesh to separate the cells from undigested tissue. The suspension was pelleted by gentle centrifugation (600 x g for 3 min) and then resuspended in modified Hanks' salt solution containing 15 mM 4-(2-hydroxyethy1)-piperazineethanesulfonic acid and 2% bovine serum albumin (Sigma Chemical Co.). Incubation was continued as above, and the pH was maintained throughout by addition of 0.1 M Na3P04. Cells were allowed to equilibrate for 30 rnin before the initiation of experiments.
PREPARATION OF SERUM SAMPLES
Blood was collected by venapuncture using a plastic syringe and was immediately transferred to either a glass tube or a polypropylene tube prechilled in an ice-Hz0 bath. Specimens were chilled and then allowed to clot at 4OC. (Maximum time never exceeded 4 hr). After centrifugation at 1000 X g at 4°C for 20 min, the serum was removed with a polypropylene pipetter and transferred to plastic tubes. Most samples were stored for 1 to 2 wk at -35°C but several were assayed immediately after preparation. Frozen specimens were rapidly thawed at 37OC (within 5 min) just before usage and were kept in an ice-Hz0 bath. Specimens were thawed only once and were then discarded after use.
NET K' TRANSPORT STUDIES
The cell suspension was adjusted with fresh incubation medium to give a packed cell volume to medium volume (hematocrit) of 3%. To determine K+ and Na+ in the medium at 0 time, 50 p1 of cell suspension was removed, centrifuged in an Eppendorf Microcentrifuge at 11,000 rpm for I rnin and the supernatant was analyzed in a Beckman flame photometer. The total K+ and Na+ concentration in the cell suspension was determined on supernatant after sonication of the cell suspension. After the addition of agonist (carbamylcholine chloride; Sigma Chemical Co.), serum, or both, samples were removed at various time intervals and centrifuged. Each assay was performed twice, and ion concentration was determined in duplicate. The amount of K+ released into the medium was expressed as percentage of the total intracellular + available for release. The amount of available intracellular K+ determined by subtracting the medium K' concentration at 0 time from the total K' concentration in the supernatant following disruption of the cell suspension by sonication.
RESULTS
The action of a cholinergic agonist on acinar cell secretory activity illustrates how net K+ transport can be utilized as a chemical marker for the detection of C F factors which affect secretion. The kinetics of the net change in K' levels in rat submandibular cells in response to stimulation by an optimal concentration of carbamylcholine is shown in Figure 1 . The rapid net efflux of K+ which accompanies the secretory response reaches a maximum at about 45 sec and results in extracellularization of 40 to SOTO of the total intracellular quantity of this ion. Net efflux is followed by a somewhat slower uptake phase in which most of the extracellularized K' re-enters the acinar cells. No net K+ release occurs in the absence of anonist. The lonarithnic doseresponse curve (Fig. 2) shows a st% response kadient with a maximum at a~~r o x i m a t e l v 2 x 10-M carbamvlcholine and a half-maximal rkiponse at ~pproximately 1 x IO-"M.
To examine the intrinsic ability of C F and normal serum to promote ion flux in submandibular cells, we incubated 2 ml of cell suspension with varying amounts of serum in the presence or absence of the secretagogue, carbamylcholine. Serum volumes of 1 to 100 p1 had no effect on enhancing K' efflux in the absence of carbamylcholine. A representative example is shown in Figure 3 . C F and normal serum volumes of 500 and 750 p1 rapidly and irreversibly damaged the cells as evidenced by increased total K+ efflux into the medium, the altered time course of K+ release, and interference with the uptake phase after carbamylcholine stimulation (Fig. 3) . Maximal stimulation of K+ release by cholinergic effectors is between 40 and 5OTo of the total intracellular amount, whereas high concentrations of serum resulted in 60 to 85% release of K+ within 10 min. The time course in the presence of high serum levels does not follow the rapid efflux and subsequent reentry phases seen with carbamylcholine alone. K+ efflux continues to increase with time, and the uptake phase is abolished. No significant differences were seen between C F and normal serum in producing these apparantly nonspecific effects. There was no effect of normal serum on the maximal carbamylcholine-stimulated K+ efflux, but the re-entry phase was inhibited partially upon addition of senlm volumes of 250 pl (Fig. 3) . Because of the nonspecific effects of normal serum and the failure to see a differential effect of C F serum on K+ transport at serum volumes 2250 pl, detailed analyses of several CF and normal serum specimens were carried out at the maximal concentration of normal serum (100 pl) which had no effect on the bioassay system. To determine if CF serum potentiates the effect of a cholinergic agonist on submandibular cells, a fixed volume (100 p1) of serum was added to cell suspensions simultaneously with the addition of different concentrations of agonist, and the maximal net K' eMux was determined after 45 sec (Fig. 4) . Serum did not elicit the emux of significantly more K' from the cells at any concentration of agonist. As shown in Figure 4 , there was no significant difference between the effect of CF and normal serum, nor was the pattern of passive eMux significantly altered from that seen in the absence of serum (Fig. 2) . No effect was observed on cellular Na+ levels. The effects of sera from seven C F and several normal individuals on K+ emux at high M) and low M) carbamylcholine concentration is summarized in Table   I .
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Because there was no observed enhancement of net K' efflux by CF serum at any agonist concentration (neither greater net extracellularization at maximal stimulation by secretagogue nor potentiation of the action of suboptimal concentrations of the agonist), the ability of CF serum to inhibit the re-entry phase of K' transport was investigated. Serum (100 p1) was added simultaneously with M agonist and the K' concentration in the medium was determined over a 10-min interval (Fig. 5) . No differential effect of the CF serum was observed either upon the net influx of K+ or upon the apparent rate of K+ influx subsequent to agonist stimulation. A summary of the data obtained for CF patients and controls is provided in Table 2 .
Several different additional control experiments also were performed to clarify certain aspects of these experiments: (1) the effect of fresh versus frozen serum; (2) I Seven CF and five normal sera were examined at M carbamylcholine; five CF and three normal sera were examined at 10-% agonist. Each was assayed in duplicate and a control with agonist but withot. serum assayed at the samc time.
-' Mean * S.D. of the percentage of total cellular K' found in medium 45 sec after addition of carbamylcholine with or without si taneous addition of serum. in glass versus in polypropylene tubes; (3) the effect of preincubating cells with serum for 10 min before the addition of secretagogue; (4) the effect of removing the albumin from the suspending medium on the activity of C F serum. No significant difference in net K+ movement was observed between the action of fresh and frozen serum, the effect of glass or plastic tubes used in serum preparation or upon preincubation of cells with serum before the addition of carbamylcholine. Removal of the albumin, which might conceivably bind and thus inactivate a serum factor, resulted in cell death with loss of most of the cellular K+ into the medium in a short period. There was no difference in the effect of C F and normal serum in this process.
DISCUSSION
Inasmuch as Spock et al. (31) first described the ability of C F serum to disrupt ciliary rhythm in rabbit tracheal explants, there has been a continuing attempt to conclusively establish the presence of unique bioactive humoral factors in C F individuals and to exploit such activities to gain better insight into the molecular basis of this disease. Among the activities reported to occur in serum, saliva, or sweat from the C F patient are inhibition of ciliary movement (2, 6, 31) , stimulation of polymorphonuclear leukocyte degranulation (S), inhibition of alveolar macrophage phagocytic activity (33) , inhibition of the glycogen debranching enzyme (1 I), and interference with cation handling during the secretory process of the salivary gland (16, 17, 32) and the svlreat gland (13, 15) . The clinical presentation in the patient implies exocrine gland target specificity if these factors have a relationship to the pathophysiology of CF. In view of the multiplicity of bioactive factors apparently associated with C F serum and the activity in saliva and sweat which may lead to elevated sweat electrolytes in CF, we sought to detect and to quantitate the action of serum factors which interfered with cation transport during exocrine gland secretory processes.
The dispersed cell suspension system of the rat submandibular gland in principle offers several technical advantages over other available bioassays: (1) large preparations of cells, predominantly of the acinar type, can be obtained so that response homogeneity during multiple assays is assured; (2) a large number of assays can be performed in a short time as compared to technically complex. time-consuming assays such as parotid retrograde perfusion; (3) secretion by the cells closely parallels that found in vivo, yet diffusion problems and complex cellular interactions are obviated; (4) the secretory response is quantitative, rapid, and reproducible; (5) there exists a broad description of the major features of the secretory process which includes secretagogue receptors and their dose response to specific agonists, kinetics of net K+ and Na+ transport and much release, and the requirement for divalent cations (23) (24) (25) .
It is a general finding that agonist stimulation of secretion in exocrine tissue is accompanied by a major change in intracellular K+ concentration as an initial, tightly coupled event (18, 20, 21, 26, 27, 30) . This also occurs in the dispersed rat submandibular cell preparation (23) . Secretagogue-stimulated release of both mucin and K ' from these acinar cells is Ca++ dependent (23, 24) .
Thus, K+ release should reflect the action of chemical effectors upon several different components of the secretory response including direct activation of the secretory response, secretagoguereceptor interaction, secretion-linked K'/Na+ transport and the mechanism of Ca"-coupling to secretion. For example, C F factor(~) might be expected to result in increased net extracellular K+ levels by exerting mechanistically different effects: (I) direct stimulation of the a-adrenergic or cholinergic receptors in the absence of exogenous "normal" secretagogue; (2) direct activation of secretion by a more distal event in the activation sequence, e.g., acting as a Ca++ ionophore (30); (3) augmentation (sensitization) of the normal cellular responses to secretagogues (hyperresponsiveness); (4) promotion of emux through an ion channel other than that influenced by normal secretagogues; (5) modification of the duration of the response to secretagogues; (6) inhibition of the re-entry phase of ion transport. In the experiments we described herein; these possibilities were examined with regard to acinar cell K' transport, both passive eMux and active transport during the re-entry phase, and none appeared to be affected differentially by C F serum. Although it is possible that the enzymatic treatment used in the preparation of the dispersed cell cultures may have altered receptors necessary to the action of C F factor(s), this seems unlikely because receptors for a-adrenergic and cholinergic agonists are intact. Alternatively, the concentration in serum of the exocrine gland-active C F factor@) may be too low to detect with this bioassay system.
The preponderance of acinar cells in the dispersed submandibular preparation (25) is an asset for the detection of C F factors which alter secretion itself but is a major limitation for the detection of alterations in processes subsequent to secretion which occur in other cell types. Thus, the ductal cell function of special interest to CF, Na+ reabsorption from the primary secretory fluid of the acinar cell (15, 16, 28) , cannot be investigated in this bioassay system. The inability of serum factors to alter secretory activity of acinar cells is consistent with Mangos' conclusion (15) that humoral factors lead to increased sweat Na+ by interfering with ductal cell reabsorption of this ion from the acinar cell primary secretory fluid. If humoral factors actually lead to the pathophysiologic changes which characterize the exocrine glands in CF, then our results suggest that their action does not involve the acinar cell in a significant and primary manner. It must be minted out that there is no proof that serum bioactive factors 16 
